Liver Function Tests Explained: What Each Test Measures

This article is for informational purposes only and does not constitute medical advice. Consult a qualified healthcare provider before making health decisions based on this content.

By MeridianMedicalCentre.com Health Research Team | Last verified: August 2026

What Liver Function Tests Are: Definition and Purpose

Liver function tests (LFTs), also called a hepatic panel or liver panel, are groups of blood tests that assess the state of your liver. Despite the name, these tests don't measure “function” alone—they measure liver enzymes, proteins, and bilirubin levels that together reveal how your liver is working and whether it's being damaged.

These tests include:

• Alanine transaminase (ALT) — an enzyme found primarily in liver cells
• Aspartate transaminase (AST) — an enzyme found in liver and other tissues
• Alkaline phosphatase (ALP) — an enzyme linked to the biliary tract (bile ducts)
• Bilirubin (total, direct, and indirect) — a breakdown product of hemoglobin
• Albumin — a protein made by the liver
• Prothrombin time (PT/INR) — measures blood clotting ability

Your doctor orders liver function tests to detect liver disease early (often before you feel symptoms), distinguish between different types of liver disorders, assess the severity of known damage, and monitor whether treatment is working. These tests are also routinely performed on people taking medications like anticonvulsants to ensure the drugs aren't harming the liver.

How Liver Function Tests Work: What Each Marker Reveals

Transaminases: ALT and AST

ALT (alanine transaminase) and AST (aspartate transaminase) are enzymes that leak from liver cells when they are damaged or inflamed. These are the most useful early warning signs of liver injury in patients whose liver still has intact function. ALT is more specific to the liver; AST is found in liver, heart, and muscle cells. When these enzymes are elevated, it signals that liver cells are being damaged—but it doesn't tell you why.

Alkaline Phosphatase (ALP)

Alkaline phosphatase is an enzyme associated with the bile ducts (the tubes that carry bile from the liver). Elevated ALP suggests obstruction of bile flow or cholestasis, often pointing to biliary tract disease rather than direct hepatocyte injury.

Bilirubin: Direct and Indirect

Bilirubin is a breakdown product of hemoglobin released when red blood cells die. The liver normally takes up this unconjugated (indirect) bilirubin, chemically modifies it through an enzyme called UDP-glucuronyl-transferase to make it water-soluble, and then excretes it in bile.

Total bilirubin levels above 17 μmol/L indicate liver disease. When levels exceed 40 μmol/L, bilirubin deposits in the skin and eyes, causing the yellow discoloration called jaundice.

Different patterns of bilirubin elevation suggest different problems:

• High unconjugated (indirect) bilirubin — suggests overproduction of bilirubin or the liver's inability to take it up and conjugate it
• High conjugated (direct) bilirubin — indicates the liver has successfully processed bilirubin, but it's backing up into the bloodstream due to obstruction in the bile ducts or hepatocyte damage

Albumin

Albumin is a key protein made by the liver that carries nutrients and drugs through the bloodstream. Low albumin suggests the liver isn't manufacturing proteins properly—a sign of chronic or severe liver disease, since the liver has large reserves of synthetic capacity.

Prothrombin Time (PT/INR)

The liver makes clotting factors. Prolonged PT/INR suggests the liver isn't producing these factors adequately—another marker of synthetic dysfunction in advanced disease.

What Research Shows: Clinical Significance and Diagnostic Patterns

Liver function tests are well-established diagnostic tools supported by decades of clinical use. They don't diagnose a specific disease on their own, but characteristic patterns help clinicians identify the type of liver problem:

• Hepatocellular injury (viral hepatitis, alcoholic hepatitis, cirrhosis) — marked elevation of ALT and AST, often with mild ALP elevation
• Cholestasis (bile duct obstruction, primary biliary cirrhosis) — marked elevation of ALP and bilirubin, more modest ALT/AST elevation
• Mixed pattern — suggests conditions like autoimmune hepatitis or drug-induced liver injury
• Cirrhosis — elevated bilirubin and PT/INR; lower albumin; variable transaminase levels

Important: Individual laboratory results must always be interpreted using the reference range provided by the specific laboratory that performed the test. Normal ranges vary significantly based on age, gender, ethnicity, and the testing method used.

Forms and Interpretation: Why Context Matters

Liver function tests are performed on a blood sample collected by venipuncture. There are no “forms” of these tests to choose from—they are objective chemical measurements. However, interpretation requires clinical context:

• A single elevated result may mean nothing; trends over time matter more
• Mild elevation in otherwise healthy people taking no medications is often benign
• The same result means different things in different clinical situations
• Other factors (hemolysis during blood draw, recent exercise, certain medications) can temporarily affect results

This is why your doctor may repeat tests or order additional investigations (ultrasound, hepatitis serology, autoimmune markers) before drawing conclusions.

Who Should Consider Liver Function Tests: Clinical Indications

Your doctor may order liver function tests if you have:

• Symptoms suggesting liver disease (jaundice, dark urine, pale stools, right-sided abdominal pain)
• Risk factors for liver disease (hepatitis exposure, heavy alcohol use, intravenous drug use, family history)
• Chronic conditions requiring liver monitoring (HIV, hepatitis B or C, autoimmune hepatitis)
• Are taking medications known to affect the liver (acetaminophen, statins, anticonvulsants, immunosuppressants)
• Have metabolic risk factors (obesity, diabetes, fatty liver disease)
• Are undergoing routine health screening
• Need to establish a baseline before starting new medication

Routine monitoring (typically twice yearly) is standard for people on hepatotoxic medications.

Safety and Interpretation: What You Should Know

Liver function tests themselves are safe—they are non-invasive blood tests. However, misinterpretation of results can lead to unnecessary anxiety or missed diagnoses. Key safety considerations:

• Don't self-diagnose: Abnormal results require professional interpretation; a single elevated enzyme doesn't diagnose liver disease
• Benign elevations are common: Many people have mild transaminase elevations that resolve spontaneously or reflect non-liver conditions
• Reference ranges matter: What's “normal” depends on your lab, your age, and your sex; an “abnormal” result from one lab may be normal at another
• Timing affects results: Recent illness, intense exercise, fasting, and medication timing can influence results
• Combined interpretation is essential: The pattern of results, not individual numbers, guides diagnosis; your doctor will consider AST-to-ALT ratios, the degree of elevation, and bilirubin fractionation